medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2015, Número 1

<< Anterior Siguiente >>

Ann Hepatol 2015; 14 (1)


First confirmed case of native polyomavirus BK nephropathy in a liver transplant recipient seven years post-transplanterferon a, ribavirin and telaprevir

Zeng Y, Magil A, Hussaini T, Kit YC, Erb SR, Marquez-Alazagara V, Yoshida EM

Idioma: Ingles.
Referencias bibliográficas: 21
Paginas: 137-140
Archivo PDF: 87.22 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Allen AM, Kim WR, Therneau TM, Larson JJ, Heimbach JK, Rule AD. Chronic kidney disease and associated mortality after liver transplantation—a time-dependent analysis usZeng Y, et al. , 2015; 14 (1): 137-140 140 ing measured glomerular filtration rate. J Hepatol 2014; 61: 286-92. doi:10.1016/j.jhep.2014.03.034

  2. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow- up study. Am J Transplant 2010; 10: 1420-7. doi:10.1111/j.1600-6143.2010.03126.x

  3. Pham PT, Pham PC, Wilkinson AH. Management of renal dysfunction in the liver transplant recipient. Current Opinion in Organ Transplantation 2009; 14: 231-9. doi:10.1097/ MOT.0b013e32832b34a4

  4. Salama M, Boudville N, Speers D, Jeffrey GP, Ferrari P. Decline in native kidney function in liver transplant recipients is not associated with BK virus infection. Liver Transpl 2008; 14: 1787-92. doi:10.1002/lt.21627

  5. Doucette KE, Pang XL, Jackson K, Burton I, Carbonneau M, Cockfield S, Preiksaitis JK. Prospective monitoring of BK polyomavirus infection early posttransplantation in nonrenal solid organ transplant recipients. Transplantation 2008; 85: 1733-6. doi:10.1097/TP.0b013e3181722ead

  6. Amir A, Shapiro R, Shulman LM, Mor E, Steinberg R, Fleishhacker H, Bergerin R, et al. BK virus infection and its effect on renal function in pediatric liver-transplant recipients: a cross-sectional, longitudinal, prospective study. Transplantation 2011; 92: 943-6. doi:10.1097/ TP.0b013e31822e0b9a

  7. Masutani K, Shapiro R, Basu A, Tan H, Wijkstrom M, Randhawa P. The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome. Am J Transplant 2012; 12: 907-18. doi:10.1111/j.1600-6143.2012.03993.x

  8. Harlow E, Crawford LV, Pim DC, Williamson NM. Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol 1981; 39: 861-9.

  9. Whiley DM, Mackay IM, Sloots TP. Detection and differentiation of human polyomaviruses JC and BK by LightCycler PCR. J Clin Microbiol 2001; 39: 4357-61. doi:10.1128/ JCM.39.12.4357-4361.2001

  10. De Gascun CF, Carr MJ. Human polyomavirus reactivation: disease pathogenesis and treatment approaches. Clinical & Developmental Immunology 2013: 373579. doi:10.1155/ 2013/373579

  11. Randhawa PS, Finkelstein S, Scantlebury V, Shapiro R, Vivas C, Jordan M, Picken MM, et al. Human polyoma virusassociated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103-9.

  12. Knowles WA. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Advances in Experimental Medicine and Biology 2006; 577: 19-45. doi:10.1007/0-387-32957-9_2

  13. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; 1: 1253-7.

  14. Gralla J, Huskey J, Wiseman AC. Trends in immune function assay (ImmuKnow; Cylex) results in the first year post-transplant and relationship to BK virus infection. Nephrology, Dialysis, Transplantation 2012; 27: 2565-70. doi:10.1093/ndt/gfr675

  15. Sharif A, Alachkar N, Bagnasco S, Geetha D, Gupta G, Womer K, Arend L, et al. Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients. Clin J Am Society Nephrol 2012: 7: 1320-7. doi:10.2215/CJN.00770112

  16. Schold JD, Rehman S, Kayle LK, Magliocca J, Srinivas TR, Meier-Kriesche HU. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transplant Int 2009; 22::626- 634. doi:10.1111/j.1432-2277.2009.00842.x

  17. Sahney S, Yorgin P, Zuppan C, Cutler D, Kambham N, Chinnock R. BK virus nephropathy in the native kidneys of a pediatric heart transplant recipient. Pediatric Transplant 2010; 14: E11-15. doi:10.1111/j.1399-3046.2008.01122.x

  18. Haririan A, Ramos ER, Drachenberg CB, Weir MR, Klassen DK. Polyomavirus nephropathy in native kidneys of a solitary pancreas transplant recipient. Transplantation 2002; 73: 1350-3.

  19. Schwarz A, Mengel M, Haller H, Niedermeyer J. Polyoma virus nephropathy in native kidneys after lung transplantation. Am J Transplant 2005; 5: 2582-5. doi:10.1111/ j.1600-6143.2005.01043.x

  20. Kusne S, Vilchez RA, Zanwar P, Quiroz J, Mazur MJ, Heilman RL, Mulligan D, et al. Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance. J Infec Dis 2012; 206: 875-80. doi:10.1093/infdis/jis469

  21. Loeches B, Valerio M, Perez M, Banares R, Ledesma J, Fogeda M, Salcedo M, et al. BK virus in liver transplant recipients: a prospective study. Transplant Proceed 2009; 41: 1033-7. doi:10.1016/j.transproceed.2009.02.021




2020     |     www.medigraphic.com